Oral Glucose-Lowering Agents for the Treatment of Type 2 Diabetes Mellitus
- Author:
Su-Yen Goh
- Publication Type:Journal Article
- Keywords:
Type 2 Diabetes Mellitus;
Hypoglycemic Agents;
Patient-centred Care;
Cardiovascular Disease;
Sodium-Glucose Transporter 2
- From:The Singapore Family Physician
2019;45(1):6-11
- CountrySingapore
- Language:English
-
Abstract:
Family physicians manage the majority of patients with type 2 diabetes mellitus (T2DM) in Singapore. Hence, they should be familiar with the profile of the many available oral glucose-lowering agents. These drugs vary in their mechanisms of action, glucose-lowering efficacy, safety profiles and treatment costs between classes – even within classes in some cases. These factors should be carefully considered for a patient-centred approach to selecting oral glucose-lowering therapy. This review aims to describe the characteristics of various oral glucose-lowering agents available to family physicians in the management of T2DM and the impact of these characteristics on the patient-centric approach to treatment decision-making.
